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Poly(ADP-ribose): a co-regulator of DNA methylation?
Abstract
The formation of multiprotein complexes is l'ordre du jour in regulatory pathways. In this issue of
Oncogene, Reale et al. report the formation of a particularly sophisticated complex of two important
regulatory enzymes, DNMT1 (DNA methyltransferase-1) and PARP-1
(poly(ADP-ribose)polymerase-1). The former evolved with a specific sequence motif binding the
enzymatic product of the latter. The product, poly(ADP-ribose), bonds the two partners into a
heterodimeric complex and, as a consequence, the catalytic function of DNMT1 is silenced. Thus,
PARP-1 becomes a conditional negative regulator of DNMT1. In a larger perspective, Reale et al.
highlight the potential role of PARP-1 as a co-regulator of DNA methylation leading to epigenetic
reprogramming of cancer cells.
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The formation of multiprotein complexes is l’ordre du jour
in regulatory pathways. In this issue of Oncogene, Reale
et al. report the formation of a particularly sophisticated
complex of two important regulatory enzymes, DNMT1
(DNA methyltransferase-1) and PARP-1 (poly(ADP-
ribose)polymerase-1). The former evolved with a speciﬁc
sequence motif binding the enzymatic product of the
latter. The product, poly(ADP-ribose), bonds the two
partners into a heterodimeric complex and, as a
consequence, the catalytic function of DNMT1 is silenced.
Thus, PARP-1 becomes a conditional negative regulator
of DNMT1. In a larger perspective, Reale et al. highlight
the potential role of PARP-1 as a co-regulator of DNA
methylation leading to epigenetic reprogramming of
cancer cells.
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During carcinogenesis, cells undergo genome-wide
hypomethylation and aberrant methylation of CpG
islands. The chains of signaling driving such changes are
not understood (for a review see Jaenisch and Bird,
2003). In human cancers, certain genes are targets of
aberrant methylation of promoter region CpG islands
and this may cause the epigenetic silencing of tumor
suppressor genes. Other CpG islands are well protected
from this silencing mechanism, even if hypermethylation
pressure is enhanced by forced overexpression of
DNMT1 (Jaenisch and Bird, 2003). One factor for
protection could be sequence context (Feltus et al.,
2003). In 1997, Caiafa’s group presented the ﬁrst
evidence that polyADP-ribosylation could be involved
(Zardo et al., 1997). Inhibition of PARP-1 induced
aberrant methylation of a CpG island in the promoter of
the Htf9 gene, demonstrating that it was not unmethy-
latable due to sequence context (Zardo and Caiafa,
1998). In the present report, the same group now
provides a plausible mechanism for how PARP-1 could
operate as a negative regulator of DNA methylation
(Reale et al., 2005). Following activation, PARP-1
forms multiple polymers of ADP-ribose that become
covalently attached to the enzyme itself. With the help
of its long polymer arms, PARP-1 recruits DNMT1 into
a complex and blocks its catalytic activity. Thus, PARP-
1 becomes a positive regulator of epigenetic stability by
protecting CpG islands from aberrant hypermethyla-
tion.
The mechanisms of targeting and activation of
PARP-1 at CpG islands are not known. With its two
zinc ﬁngers, PARP-1 binds to and is activated by DNA
strand breaks (for a review see Rouleau et al., 2004).
Another option is that PARP-1 binds to speciﬁc
undamaged linear and stem-loop DNA structures,
including some speciﬁc double-stranded sequences,
which may be more potent activators of PARP-1s
catalytic function than damaged DNA. PARP-1 can
also be stimulated by association with proteins, such as
transcription factors or transcriptional coactivators (for
a review see Kraus and Lis, 2003; Rouleau et al., 2004).
Finally, PARP-1 operates at the interface of transcrip-
tional activation and chromatin decondensation. Sprad-
lings group demonstrate the colocalization of PARP-1
activity in areas of chromatin decondensation (‘puffs’)
and high transcriptional activity in Drosophila and, most
importantly, the critical dependence of these processes
on PARP-1 function (Tulin and Spradling, 2003). It will
be a rewarding challenge to elucidate the targeting and
the activating principle for PARP-1 in silencing DNA
methylation.
DNMT1 is just the latest example of a protein being
recruited into a complex by PARP-1-bound polymers.
Several proteins of the genome surveillance system, such
as p53, p21, DNA-PK, MSH6, XPA, and XRCC1
contain a polymer-binding sequence motif (Pleschke
et al., 2000). All these proteins form a tight complex
with automodiﬁed PARP-1 but not with polymer-free
enzyme. A particularly impressive example has been
demonstrated in living cells for the assembly of the base
excision repair complex (El-Khamisy et al., 2003; Okano
et al., 2003). Within less than 2min of DNA base
damage, PARP-1 forms ADP-ribose polymers and
recruits XRCC1 to repair foci. Mutations in the
polymer-binding site abrogate polymer-binding and
recruitment of XRCC1 to repair foci. In this case, the
interaction of XRCC1 with its other partners to form a
functional repair complex, such as DNA ligase III or
DNA polymerases b and e, is not impaired (El-Khamisy
et al., 2003; Okano et al., 2003). Another example –
albeit with different outcome – is the tumor suppressor
protein p53. Both p53 and PARP-1 are activated by
DNA breaks, but the PARP-1-bound polymers recruit
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p53 into a complex and prevent it from acting as a
transcription factor. p53 contains three polymer-binding
sequence motifs in the sequence-speciﬁc DNA-binding
domain (Malanga et al., 1998). Finally, PARP-1 may
operate in yet another mode, this time activating the
dormant catalytic activities of DNA topoisomerase I
getting stuck on DNA breaks. Topo I controls DNA
supercoiling, allowing topological changes that are
necessary for DNA transactions. However, when
operating on damaged DNA, the enzyme may get
trapped in a covalent complex with DNA and pose a
threat to genomic stability. PARP-1-bound polymers
target two sequence motifs in topo I and reactivate two
speciﬁc domain functions of these enzymes (Malanga
and Althaus, 2004). As a result, topo I removes itself
from DNA and repairs the damage. Thus, PARP-1 also
plays a role in the constitutive maintenance of genomic
stability.
Proteins bonded into a complex with PARP-1 can be
released by the enzyme poly(ADP-ribose)glycohydrolase
(PARG), which degrades polymers both endo- and
exoglycosidically. In fact, ADP-ribose polymers have a
relatively short half-life in vivo regardless whether
PARP-1 is activated by DNA damage or during
transcription (for a review see Rouleau et al., 2004). It
will therefore be of considerable interest to see how
interference with PARG activity affects DNA methyla-
tion. Finally, it is possible that DNMT1 associates with
ADP-ribose polymers that were synthesized by other
members of the PARP family (for a review see Rouleau
et al., 2004). In addition, most of these PARPs engage in
a heteromodiﬁcation reaction leading to the post-
translational poly ADP-ribosylation of other proteins.
Several of these have been implicated in chromatin
remodeling and they could interact with DNMT1 via
attached polymers (Rouleau et al., 2004).
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